Effect of Fenofibrate and Ezetimibe Combination Treatment on Lipid

INTERVENTION: Fenofibrate(200mg)+Ezetimibe(10mg)group 52 weeks Fenofibrate(200mg) group 52 weeks Ezetimibe(10mg) group 52 weeks CONDITION: Type IIb Dyslipidaemia PRIMARY OUTCOME: Per cent change in LDL‐C from baseline ; Per cent change in TG from baseline SECONDARY OUTCOME: Incidence rate (AE); Per cent change in HDL‐C from baseline INCLUSION CRITERIA: Main criteria for inclusion: Wash Out period;‐4 weeks 1)Subjects who are able to give written informed consent 2)Male and female, and age is over 20 years 3)Patients with combined hyperlipidaemia ;400>TG>200mg/dL and LDL‐C>140mg/dL